QIAGEN NV (QGEN)

39.52
NYSE : Health Technology
Prev Close 39.62
Day Low/High 39.36 / 39.80
52 Wk Low/High 32.33 / 41.55
Avg Volume 1.19M
Exchange NYSE
Shares Outstanding 226.97M
Market Cap 8.99B
EPS 0.80
P/E Ratio 48.32
Div & Yield N.A. (N.A)

Latest News

Inovio And QIAGEN Establish Collaboration To Develop Diagnostic Test For VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer

Inovio And QIAGEN Establish Collaboration To Develop Diagnostic Test For VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer

Liquid biopsy-based Precision Medicine test to guide patient selection for Inovio's VGX-3100

QIAGEN Posts 2018 Annual Report On Its Website

QIAGEN Posts 2018 Annual Report On Its Website

QIAGEN N.V.

QIAGEN N.V. To Report First Quarter 2019 Results

QIAGEN N.V. To Report First Quarter 2019 Results

QIAGEN N.V.

TheStreet Quant Rating: B (Buy)